Back
Morgan Stanley Vs. Keros Therapeutics Industry Stock Comparison
Buy
57
MS
Morgan Stanley
Last Price:
102.46
Seasonality Move:
1.18%
Sell
35
KROS
Keros Therapeutics
Last Price:
55.82
Seasonality Move:
37.33%
Buy
57
Morgan Stanley (MS)
is a Buy
Is Morgan Stanley a Buy, Sell or Hold?
- The current Morgan Stanley [MS] share price is $100.73. The Score for MS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- MS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $57.32. The Score for KROS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MS Stock Price Chart
What is Morgan Stanley's stock price today?
-
The Morgan Stanley share price today is $100.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MS is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $57.32
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
MS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 54.24 | Buy |
| Chaikin Money Flow: | 2417658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.15 - 102.07) | Buy |
| Bollinger Bands (100): | (95.46 - 102.36) | Buy |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.54 | Buy |
| Relative Strength Index (14 RSI): | 69.78 | Buy |
| Chaikin Money Flow: | 11894 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.63 - 54.93) | Buy |
| Bollinger Bands (100): | (44.93 - 54.13) | Buy |
MS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 98.56 | Buy |
| 20-day SMA: | 99.88 | Buy |
| 50-day SMA: | 100.34 | Buy |
| 200-day SMA: | 93.81 | Buy |
| 8-day EMA: | 99.33 | Buy |
| 20-day EMA: | 99.37 | Buy |
| 50-day EMA: | 99.36 | Buy |
| 200-day EMA: | 94.7 | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.81 | Buy |
| 20-day SMA: | 51.2 | Buy |
| 50-day SMA: | 49.36 | Buy |
| 200-day SMA: | 52.15 | Buy |
| 8-day EMA: | 55.34 | Buy |
| 20-day EMA: | 52.61 | Buy |
| 50-day EMA: | 50.31 | Buy |
| 200-day EMA: | 49.54 | Buy |
Morgan Stanley Earnings Growth & MS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.19 per share, an increase this year of $1.46 per share, and an increase next year of $0.64 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.31 per share, and a decrease next year of $0.43 per share.
Morgan Stanley Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||